← All trials
NCT04814264
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2021
- Primary completion
- May 31, 2022
- Completion date
- Sep 30, 2022
- First posted
- Mar 24, 2021
- Last posted
- Oct 21, 2021
- Enrollment
- 268
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- McMaster UniversityLead sponsor
- McMaster UniversityReponsible party - principal investigator
- McMaster UniversityOverall official - principal investigator
- Canadian Institutes of Health Research (CIHR)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.